Matthew Peak

3.3k total citations
106 papers, 2.4k citations indexed

About

Matthew Peak is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Molecular Biology. According to data from OpenAlex, Matthew Peak has authored 106 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pediatrics, Perinatology and Child Health, 22 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Matthew Peak's work include Pharmaceutical studies and practices (38 papers), Pancreatic function and diabetes (16 papers) and Pharmacovigilance and Adverse Drug Reactions (10 papers). Matthew Peak is often cited by papers focused on Pharmaceutical studies and practices (38 papers), Pancreatic function and diabetes (16 papers) and Pharmacovigilance and Adverse Drug Reactions (10 papers). Matthew Peak collaborates with scholars based in United Kingdom, Poland and Brazil. Matthew Peak's co-authors include Loranne Agius, M. Turner, Anthony J Nunn, Mohamed A. Alhnan, Abdullah Isreb, Molham Al‐Habori, James L. Ford, Munir Pirmohamed, Roberta Richey and Utpal Shah and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Matthew Peak

103 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Peak United Kingdom	28	639	624	563	399	381	106	2.4k
Elena Cavarretta Italy	26	41 0.1×	767 1.2×	402 0.7×	128 0.3×	71 0.2×	123	2.8k
José M. Castellano Spain	24	65 0.1×	309 0.5×	259 0.5×	54 0.1×	153 0.4×	70	1.8k
Arjun K. Ghosh United Kingdom	28	147 0.2×	315 0.5×	292 0.5×	136 0.3×	174 0.5×	152	2.6k
Lawrence A. Trissel United States	19	532 0.8×	193 0.3×	344 0.6×	160 0.4×	24 0.1×	142	2.0k
Hirofumi Ohnishi Japan	31	88 0.1×	700 1.1×	464 0.8×	101 0.3×	804 2.1×	189	3.4k
Chia‐Te Kung Taiwan	25	69 0.1×	439 0.7×	448 0.8×	337 0.8×	106 0.3×	157	2.5k
Rebecca L. Johnson United States	28	169 0.3×	215 0.3×	1.7k 3.0×	69 0.2×	65 0.2×	124	3.2k
Yuqing Zhang China	25	53 0.1×	199 0.3×	273 0.5×	56 0.1×	277 0.7×	120	2.4k
Donna L. Carden United States	28	89 0.1×	594 1.0×	855 1.5×	216 0.5×	137 0.4×	87	3.8k
Yi‐Ting Lin Taiwan	26	58 0.1×	376 0.6×	134 0.2×	79 0.2×	59 0.2×	96	1.6k

Countries citing papers authored by Matthew Peak

Since Specialization

Citations

This map shows the geographic impact of Matthew Peak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Peak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Peak more than expected).

Fields of papers citing papers by Matthew Peak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Peak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Peak. The network helps show where Matthew Peak may publish in the future.

Co-authorship network of co-authors of Matthew Peak

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Peak. A scholar is included among the top collaborators of Matthew Peak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Peak. Matthew Peak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lima, Elisângela da Costa, et al.. (2023). The Utility of the Liverpool Adverse Drug Reaction Assessment Tools in the Evaluation of Chemotherapy-Induced Nausea and Vomiting in Children. SHILAP Revista de lepidopterología. 69(3).

Duncan, Jennifer C, et al.. (2023). The use of Special-Order products in England between 2012 and 2020: An insight into the need for Point-of-Care manufacturing. International Journal of Pharmaceutics. 637. 122801–122801. 1 indexed citations

McNamara, Paul, et al.. (2022). Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial. PLoS ONE. 17(2). e0263044–e0263044.

Araújo, Dyego Carlos Souza Anacleto de, Isabela Heineck, Marta Maria de França Fonteles, et al.. (2022). Adverse Drug Reactions to Anti-infectives in Hospitalized Children: A Multicenter Study in Brazil. Journal of the Pediatric Infectious Diseases Society. 12(2). 76–82. 2 indexed citations

Duncan, Jennifer C, Louise Bracken, Anthony J Nunn, Matthew Peak, & M. Turner. (2022). Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children. International Journal of Clinical Pharmacy. 44(6). 1394–1405. 2 indexed citations

Rosala‐Hallas, Anna, Ashley P Jones, Paula Williamson, et al.. (2022). Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop. BMJ Open. 12(3). e052943–e052943. 3 indexed citations

Waldron, Cherry-Ann, Emma Thomas‐Jones, Jolanta Bernatoniene, et al.. (2022). Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial. BMJ Open. 12(1). e047490–e047490. 3 indexed citations

Khoder, Mouhamad, et al.. (2021). Controlling drug release with additive manufacturing-based solutions. Advanced Drug Delivery Reviews. 174. 369–386. 53 indexed citations

Bensouda, Y., Jumpei Saito, Liv Mathiesen, et al.. (2021). Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study. Pharmaceutics. 13(10). 1721–1721. 10 indexed citations

10.

Nielsen, Maryke, Paul Baines, Rebecca Jennings, et al.. (2021). Procalcitonin, C-reactive protein, neutrophil gelatinase-associated lipocalin, resistin and the APTT waveform for the early diagnosis of serious bacterial infection and prediction of outcome in critically ill children. PLoS ONE. 16(2). e0246027–e0246027. 7 indexed citations

11.

Jones, Ashley P, Frances Sherratt, Matthew Peak, et al.. (2020). Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study. Health Technology Assessment. 24(36). 1–152. 4 indexed citations

12.

Rosala‐Hallas, Anna, Ashley P Jones, Emma Bedson, et al.. (2020). National survey of feasibility of NIV trials for management of children with bronchiolitis. BMJ Paediatrics Open. 4(1). e000780–e000780. 2 indexed citations

13.

Bracken, Louise, Fiona Wilson, Udeme Ohia, et al.. (2020). Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)). BMJ Open. 10(10). e036508–e036508. 25 indexed citations

14.

Carter, Bernie, David Porter, Steven Lane, et al.. (2019). Being ‘at-home’ on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents’ experiences of paediatric OPAT. Archives of Disease in Childhood. 105(3). 276–281. 13 indexed citations

15.

Carter, Bernie, Enitan D. Carrol, David Porter, et al.. (2018). Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review. BMJ Open. 8(11). e021603–e021603. 12 indexed citations

16.

Richey, Roberta, Utpal Shah, Matthew Peak, et al.. (2013). Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatrics. 13(1). 81–81. 110 indexed citations

17.

Bellis, Jennifer R, Jamie J Kirkham, Elizabeth J. Conroy, et al.. (2013). Adverse drug reactions and off-label and unlicensed medicines in children: a nested case?control study of inpatients in a pediatric hospital. BMC Medicine. 11(1). 238–238. 94 indexed citations

18.

Blair, Joanne, John W Gregory, & Matthew Peak. (2012). Insulin delivery by multiple daily injections or continuous subcutaneous insulin infusion in childhood: addressing the evidence gap. Practical Diabetes. 29(2). 47–48. 1 indexed citations

19.

Aiston, Susan, Matthew Peak, & Loranne Agius. (2000). Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: the role of increased phosphorylase activity. Diabetologia. 43(5). 589–597. 23 indexed citations

20.

Agius, Loranne & Matthew Peak. (1991). Interactions of okadaic acid with insulin action in hepatocytes: role of protein phosphatases in insulin action. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1095(3). 243–248. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact